Skip to main content

Table 1 IRU characteristics

From: Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy—a 5-year study from Singapore

Number of patients, n 30
Gender, n (%)
 Male 26 (86.7)
 Female 4 (13.3)
Race, n (%)
 Chinese 25 (83.3)
 Malay 3 (10.0)
 Indian 1 (3.3)
 Others 1 (3.3)
Age, years; mean (SD)
 At IRU diagnosis 47.9 (10.7)
CD4 count, cells/μL; median (IQR)
 At HAART commencement 20.0 (15.0–62.0)
 At IRU diagnosis 210.0 (139.8–289.5)
 At CMVR diagnosis 28.5 (10.5–61.8)
 Difference from HAART to IRU diagnosis 155.5 (66.0–228.0)
Duration, days; median (IQR)
 From HIV diagnosis to HAART commencement 100.5 (61.0–210.0)
 From HAART initiation to IRU diagnosis 214.0 (118.0–763.0)
 From CMVR diagnosis to IRU diagnosis 136.5 (26.0–618.5)